rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mary Fisher

Director

Company insider

Files Form 4 as: Director, Dermata Therapeutics; Director, Sientra; Director, Tempest Therapeutics; Director, Zeltiq Aesthetics; Chief Operating Officer, Acorda Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
220
Buys
1
Sells
14
Bought
$101K
Sold
$4.4M
Companies
5
Companies where not an officer
4
First trade
15 Feb 2006
Last trade
2 Jan 2026
Last filed
6 Jan 2026

Companies traded

Where they are an officer
Acorda TherapeuticsOfficer · last 2 Jul 20070 buys · 10 sells
Everywhere else they filed: board seats, 10% stakes, other companies
DRMA Dermata TherapeuticsDirector · Biotechnology · last 2 Jan 20260 buys · 0 sells
SientraDirector · last 15 Jun 20230 buys · 0 sells
TPST Tempest TherapeuticsDirector · Biotechnology · last 7 Dec 20181 buy · 0 sells
Zeltiq AestheticsDirector · last 28 Apr 20170 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Jan 2026filed 6 Jan 2026DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—2,500 at $0.00filing
2 Jan 2026filed 6 Jan 2026DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—2,500 at $0.00filing
21 Jan 2025filed 23 Jan 2025DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—196,851filing
21 Jan 2025filed 23 Jan 2025DRMA Dermata TherapeuticsBiotechnologySEC FORM 4 Code A—196,851filing
13 Jan 2025filed 14 Jan 2025DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
4 Jan 2024filed 5 Jan 2024DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
15 Jun 2023filed 20 Jun 2023SientraSEC FORM 4 Code A—12,000 at $0.00filing
6 Oct 2022filed 7 Oct 2022DRMA Dermata TherapeuticsBiotechnologySEC FORM 4 Code A—9,810 at $0.00filing
7 Jul 2022filed 8 Jul 2022DRMA Dermata TherapeuticsBiotechnologySEC FORM 4 Code A—8,602 at $0.00filing
9 Jun 2022filed 13 Jun 2022SientraSEC FORM 4 Code A—103,306 at $0.00filing
7 Apr 2022filed 8 Apr 2022DRMA Dermata TherapeuticsBiotechnologySEC FORM 4 Code A—5,031 at $0.00filing
3 Jan 2022filed 5 Jan 2022DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
17 Aug 2021filed 17 Aug 2021DRMA Dermata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
10 Jun 2021filed 15 Jun 2021SientraSEC FORM 4 Code A—16,870 at $0.00filing
5 Jun 2020filed 9 Jun 2020SientraSEC FORM 4 Code A—27,717 at $0.00filing
14 Jun 2019filed 18 Jun 2019SientraSEC FORM 4 Code A—19,320 at $0.00filing
1 Jan 2019filed 10 Jan 2019SientraSEC FORM 4 Code A$152K11,934 at $12.71filing
7 Dec 2018filed 11 Dec 2018TPST Tempest TherapeuticsBiotechnologySEC FORM 4 Code A—355 at $0.00filing
28 Sep 2018filed 2 Oct 2018TPST Tempest TherapeuticsBiotechnologySEC FORM 4 Code A—6,851 at $0.00filing
4 Jul 2018filed 6 Jul 2018TPST Tempest Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,000 at $0.00filing

News

Tempest Therapeutics, Inc. (NASDAQ:TPST) Shares Shorted: Short Interest Up 73.6% in SeptemberTPST · dailypolitical.com · 17 Oct 2026Tempest Therapeutics (NASDAQ:TPST) Upgraded to "Sell" at Wall Street ZenTPST · dailypolitical.com · 11 Oct 2026

0 headlines in the last 90 days name Mary Fisher; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1
Not placed14

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.